Representing the UK’s insurance, long-term savings and investment industry | Contact us

Solvency II Conference

31 October 2013 09:00 - 17:00

Grange Tower Bridge, 45 Prescot St, London E1 8GP

Solvency II presents insurers with a number of questions to be answered, not least in relation to how their product provision and investment practices might look in a post-Solvency II world.

For more information about the conference and speakers download the conference programme (pdf 1MB).

Twitter

Read updates from @britishinsurers and others on the official conference hashtag #SIIFuture.

Summary

Read Otto Thoresen's closing remarks from the conference.

Photos

From the ABI Flickr photostream

Blogs

Join the debate

Have your say on how insurers can play a key role in finding solutions to the issues that will shape our world in the 2020s and beyond. Join the debate.

 

Sponsors

Wolters Kluwer

PA Consulting

Exhibitors

Invoke

 

 CIMCON Software

 

KPMG

 

Tagetik

Price

ABI members Price: £199.00 excl VAT

Non-members Price: £299.00 excl VAT

Breakout Sessions

Solvency II rules will lead to insurers having to collect, compile and disseminate large amounts of information about their business operations; both to regulators and the general public. How will the industry cope with these renewed data demands and the increased expectations of regulators to be provided with a wealth of information to tight deadlines? What does increased disclosure mean for the industry, both in terms of challenges and the potential benefits? Analysts have often spoken of the complicated task of interpreting insurers’ disclosures – what will they be looking for?

UK insurers write a large number of annuities every year, helping to provide people with an essential regular income in retirement. With Omnibus II negotiations set to agree the rules under which these annuities are provided to those in society most in need, what does the future hold for the provision of the popular retirement product?

The release of a list of ‘globally systemically important’ insurers by the Financial Stability Board has meant that insurers are unlikely to escape the increased scrutiny brought by a work stream that originally focused on the banking industry. What are the next steps in this project likely to be, at a domestic and international level? What are the implications for insurers’ capital?

The move towards Solvency II is being promoted by EIOPA and national regulators through the development of interim measures in the period leading up to full implementation; seeking to avoid a further fragmented European rulebook. What are the challenges (for regulators) of implementing a temporary, voluntary rulebook and (for insurers) of developing systems, policies and processes before the rest of the rules – in many cases fundamental to the operation of the regime – are not complete?

Due to the business that they underwrite, insurers are natural providers of long-term investment. Economies need this type of investment in order to promote growth and – especially in the current economic climate – this is hard to come by, especially with banks withdrawing from funding markets and showing little appetite for their lending operations to make a return to their pre-crisis levels. What barriers exist to insurers carrying out an optimal role in relation to investment and how might they be overcome? What needs to happen in order to ensure the continued – and enhanced – role of insurers in this regard?

London – and Europe more generally – is a leading marketplace for global insurance. With the possibility of European insurers’ international competitiveness being affected by the new Solvency II rules, what needs to be done before finalisation of the regime in order to minimise such an impact? Which countries are the major markets on which the focus has been placed up until now, where do they stand in the equivalence debate and what progress has been made by policymakers in finding a workable solution?

This conference was held on 31 October 2013. Registrations can no longer be made.